Older Surgical Procedure for Pelvic Prolapse Repair Prevails in Randomized Trial
A long-time surgical standard for pelvic organ prolapse repair prevailed in a comparison against a newer technique that currently predominates in some parts of the world. Sacrospinous hysteropexy failed to meet noninferiority criteria versus the Manchester procedure for the primary composite outcome of treatment success, with the latter achieving success in 87.3% of patients compared […]
‘Practice Changing’ Trial on Activity Recs After Prolapse Surgery
Telling patients who undergo pelvic organ prolapse (POP) surgery they can resume physical activity and work as soon as they’re able to resulted in noninferior anatomic and symptomatic outcomes compared with standard recommendations, a randomized trial showed. Of 107 women who underwent minimally invasive surgery at a single center, maximum anatomic POP support loss and […]
Study Leaves Transvaginal Mesh Controversy at Impasse
Transvaginal mesh proved noninferior to native tissue repair for vaginal prolapse but missed the superiority target in an FDA-mandated, postmarket, prospective parallel-cohort study. The 36-month composite treatment success rates were 89.3% with mesh repair and 80.2% with native tissue repair, falling within the prespecified 12% margin for noninferiority but not achieving superiority. However, mesh demonstrated […]